ABT
ABBOTT LABORATORIES
ABBOTT LABORATORIES (ABT) has 13 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Apr 29, 2026.
Insiders have net bought $1.1M over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Robert Ford
- Employees:114,000
- HQ:Abbott Park, IL, US
- IPO:1980-03-17
Insider Buying
$1.1M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$162.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
STARKS DANIEL JFirst filing | Insider | Purchase | 10,000 | $927K | Apr 28 | SEC ↗ |
Boudreau Philip PFirst filing | EVP AND CFO | Purchase | 2,200 | $201K | Apr 27 | SEC ↗ |
Congress trading ABT
See timeline →- DRep. Julie JohnsonSale$1,001 - $15,0002026-05-12
- DRep. Gilbert CisnerosSale$1,001 - $15,0002026-05-15
- DRep. Josh GottheimerSale$1,001 - $15,0002026-05-27
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
ABBOTT LABORATORIES is in the Healthcare sector.